{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:03:23Z","timestamp":1790874203361,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clml.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:39:39Z","timestamp":1786549179000},"page":"e1160-e1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0259-1258","authenticated-orcid":false,"given":"Ameed","family":"Bawwab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1402-4498","authenticated-orcid":false,"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3608-5826","authenticated-orcid":false,"given":"Lana","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moath","family":"Albliwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0428-3505","authenticated-orcid":false,"given":"John","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"El-Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Nurse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Abuamsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-4512","authenticated-orcid":false,"given":"Yomna","family":"Abu-Farsakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9605-1539","authenticated-orcid":false,"given":"Ahmed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-9130","authenticated-orcid":false,"given":"Muaz Alsabbagh","family":"Alchirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Nakitandwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Bosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerana Bangalore","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Alban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akriti G.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Balderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-8647","authenticated-orcid":false,"given":"Abhay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-1309","authenticated-orcid":false,"given":"Aaron T.","family":"Gerds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Sobecks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-5902","authenticated-orcid":false,"given":"Anjali S.","family":"Advani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty E.","family":"Carraway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-0010","authenticated-orcid":false,"given":"Caroline","family":"Astbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3289-2333","authenticated-orcid":false,"given":"Moaath K.","family":"Mustafa Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clml.2026.08.005_bib0001","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: a review","volume":"10","author":"Sekeres","year":"2024","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.clml.2026.08.005_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.005_bib0003","unstructured":"SEER. Cancer stat facts: leukemia\u2014acute myeloid leukemia (AML). 2026. (Accessed Jan 06, 2026). Available from https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"issue":"10393","key":"10.1016\/j.clml.2026.08.005_bib0004","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"15","key":"10.1016\/j.clml.2026.08.005_bib0005","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2012-03-419622","article-title":"A novel hierarchical prognostic model of AML solely based on molecular mutations","volume":"120","author":"Grossmann","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.clml.2026.08.005_bib0006","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2010.32.8500","article-title":"Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system","volume":"29","author":"R\u00f6llig","year":"2011","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.clml.2026.08.005_bib0007","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1200\/JCO.2012.43.4738","article-title":"Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia","volume":"30","author":"Mr\u00f3zek","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clml.2026.08.005_bib0008","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.08.005_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-023-01480-y","article-title":"Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia","volume":"16","author":"Bahaj","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.clml.2026.08.005_bib0010","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-022-32103-8","article-title":"Unified classification and risk-stratification in acute myeloid leukemia","volume":"13","author":"Tazi","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.clml.2026.08.005_bib0011","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.2025031480","article-title":"2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party","volume":"147","author":"Cloos","year":"2026","journal-title":"Blood"},{"issue":"3\u20135","key":"10.1016\/j.clml.2026.08.005_bib0012","article-title":"An empirical assessment of the cost of dichotomization of the outcome of clinical trials","volume":"45","author":"van Zwet","year":"2026","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.clml.2026.08.005_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.clml.2026.08.005_bib0014","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The5th editionof the World Health Organization Classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.clml.2026.08.005_bib0015","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2026.08.005_bib0016","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2026.08.005_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"9","key":"10.1016\/j.clml.2026.08.005_bib0018","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ajh.70000","article-title":"Impact of cytogenetic response to therapy on long-term survival in acute myeloid leukemia","volume":"100","author":"Hanna","year":"2025","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.clml.2026.08.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70465","article-title":"Cytokine receptor and JAK\/STAT pathway mutations in acute myeloid leukemia: prevalence and clinical impact","volume":"132","author":"Albliwi","year":"2026","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2026.08.005_sbref0020","series-title":"R: a language and environment for statistical computing","year":"2024"},{"issue":"10388","key":"10.1016\/j.clml.2026.08.005_bib0021","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(23)00464-6","article-title":"Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Erba","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clml.2026.08.005_bib0022","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clml.2026.08.005_bib0023","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ajh.24140","article-title":"Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade","volume":"90","author":"Badar","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clml.2026.08.005_bib0024","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood-2011-07-367508","article-title":"Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies","volume":"119","author":"Kayser","year":"2012","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.clml.2026.08.005_bib0025","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","article-title":"Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype","volume":"26","author":"Breems","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clml.2026.08.005_bib0026","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.clml.2026.08.005_bib0027","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1158\/1078-0432.CCR-20-2272","article-title":"Acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations \u2013 a distinct stem cell disorder","volume":"26","author":"Sill","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.clml.2026.08.005_bib0028","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/s41375-019-0550-5","article-title":"TP53 deficiency permits chromosome abnormalities and karyotype heterogeneity in acute myeloid leukemia","volume":"33","author":"Cazzola","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.clml.2026.08.005_bib0029","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome","volume":"119","author":"R\u00fccker","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clml.2026.08.005_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jcp-2024-209954","article-title":"Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an international TP53 investigators Network (iTiN) study","volume":"78","author":"Pandiri","year":"2025","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.clml.2026.08.005_bib0031","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijrobp.2026.03.006","article-title":"Tumor purity as a prognostic and predictive biomarker of postoperative radiation therapy outcomes in stage IIIA-N2 Non-Small cell lung cancer: A transcriptomic analysis from the lung ART trial","volume":"126","author":"Zrafi","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clml.2026.08.005_bib0032","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/his.13891","article-title":"Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study","volume":"75","author":"Dufraing","year":"2019","journal-title":"Histopathology"},{"issue":"21","key":"10.1016\/j.clml.2026.08.005_bib0033","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1093\/bioinformatics\/btz406","article-title":"TPES: tumor purity estimation from SNVs","volume":"35","author":"Locallo","year":"2019","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.clml.2026.08.005_bib0034","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3324\/haematol.2016.163584","article-title":"Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia","volume":"102","author":"Wang","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2026.08.005_bib0035","article-title":"Single cell sequencing in acute myeloid leukemia: Linking genotype to functional phenotype for precision risk stratification and treatment decisions","volume":"106174","author":"Anandappa","year":"2026","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2026.08.005_bib0036","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Ley, T.J., Miller, C., Ding, L., Raphael, B.J., Mungall, A.J., Robertson, A., Hoadley, K., Triche, T.J., Jr, Laird, P.W., Baty, J.D., Fulton, L.L., Fulton, R., Heath, S.E., Kalicki-Veizer, J., Kandoth, C., Klco, J.M., Koboldt, D.C., Kanchi, K.L., Kulkarni, S., \u2026 Eley, G. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059\u20132074. doi:10.1056\/NEJMoa1301689","DOI":"10.1056\/NEJMoa1301689"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:17:03Z","timestamp":1790871423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2152265026002661"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}